Research graph
References from Clinicopathologic Characteristics of Somatic <i>TP53</i> Mutations in Philadelphia Chromosome–Negative Myeloproliferative Neoplasms: A Systematic Review. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3390/cancers17193142
10.3390/cancers17193142 · External reference
Pathogenesis and Management of High Molecular Risk Myeloproliferative Neoplasms
2025 · External reference
10.1016/j.clml.2025.02.003
10.1016/j.clml.2025.02.003 · External reference
10.1182/blood.2022015850
10.1182/blood.2022015850 · External reference
10.1002/ajh.26772
10.1002/ajh.26772 · External reference
10.1038/s41408‐025‐01290‐0
10.1038/s41408‐025‐01290‐0 · External reference
10.1111/bjh.20187
10.1111/bjh.20187 · External reference
10.1038/leu.2017.230
10.1038/leu.2017.230 · External reference
10.1002/ajh.27609
10.1002/ajh.27609 · External reference
10.1002/ajh.27670
10.1002/ajh.27670 · External reference
Impact of TP53 on Outcome of Patients With Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation
2023 · External reference
10.1038/s41591‐020‐1008‐z
10.1038/s41591‐020‐1008‐z · External reference
10.3390/cancers14184485
10.3390/cancers14184485 · External reference
10.1182/bloodadvances.2018024018
10.1182/bloodadvances.2018024018 · External reference
10.1182/bloodadvances.2018021469
10.1182/bloodadvances.2018021469 · External reference
10.1038/s41375‐026‐02885‐7
10.1038/s41375‐026‐02885‐7 · External reference
Genomic Profiling of Blast Phase in Philadelphia‐Negative Myeloproliferative Neoplasms
2017 · External reference
10.1182/blood.v128.22.4281.4281
10.1182/blood.v128.22.4281.4281 · External reference
10.1182/blood‐2019‐132014
10.1182/blood‐2019‐132014 · External reference
10.1186/s13045‐017‐0417‐z
10.1186/s13045‐017‐0417‐z · External reference
10.1158/2159‐8290.cd‐22‐0332
10.1158/2159‐8290.cd‐22‐0332 · External reference
Prognostic Impact of 'Multi‐Hit' Versus' Single‐Hit' Tp53 Alteration in Patients With Acute Myeloid Leukemia: Results From the Consortium on Myeloid Malignancies and Neoplastic Diseases
10.3324/haematol.2024.285000 · 2024 · External reference
10.1056/nejmoa1716614
10.1056/nejmoa1716614 · External reference
10.1002/ajh.26772
10.1002/ajh.26772 · ExternalCitation · doi-reference
10.1002/ajh.27609
10.1002/ajh.27609 · ExternalCitation · doi-reference
10.1002/ajh.27670
10.1002/ajh.27670 · ExternalCitation · doi-reference
10.1016/j.clml.2025.02.003
10.1016/j.clml.2025.02.003 · ExternalCitation · doi-reference
10.1038/leu.2017.230
10.1038/leu.2017.230 · ExternalCitation · doi-reference
10.1038/s41375‐026‐02885‐7
10.1038/s41375‐026‐02885‐7 · ExternalCitation · doi-reference
10.1038/s41408‐025‐01290‐0
10.1038/s41408‐025‐01290‐0 · ExternalCitation · doi-reference
10.1038/s41591‐020‐1008‐z
10.1038/s41591‐020‐1008‐z · ExternalCitation · doi-reference
10.1056/nejmoa1716614
10.1056/nejmoa1716614 · ExternalCitation · doi-reference
10.1111/bjh.20187
10.1111/bjh.20187 · ExternalCitation · doi-reference
10.1158/2159‐8290.cd‐22‐0332
10.1158/2159‐8290.cd‐22‐0332 · ExternalCitation · doi-reference
10.1182/blood.2022015850
10.1182/blood.2022015850 · ExternalCitation · doi-reference
10.1182/blood.v128.22.4281.4281
10.1182/blood.v128.22.4281.4281 · ExternalCitation · doi-reference
10.1182/bloodadvances.2018021469
10.1182/bloodadvances.2018021469 · ExternalCitation · doi-reference
10.1182/bloodadvances.2018024018
10.1182/bloodadvances.2018024018 · ExternalCitation · doi-reference
10.1182/blood‐2019‐132014
10.1182/blood‐2019‐132014 · ExternalCitation · doi-reference
10.1186/s13045‐017‐0417‐z
10.1186/s13045‐017‐0417‐z · ExternalCitation · doi-reference
Prognostic Impact of 'Multi‐Hit' Versus' Single‐Hit' Tp53 Alteration in Patients With Acute Myeloid Leukemia: Results From the Consortium on Myeloid Malignancies and Neoplastic Diseases
10.3324/haematol.2024.285000 · ExternalCitation · doi-reference
10.3390/cancers14184485
10.3390/cancers14184485 · ExternalCitation · doi-reference
10.3390/cancers17193142
10.3390/cancers17193142 · ExternalCitation · doi-reference
